Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Heart Journal

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AHJ.2005.09.015PMID 16824829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intervention study

  2007cited by this paper
• Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

  2005cited by this paper
• Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.

  2005cited by this paper
• UK prospective diabetes study (UKPDS)

  2004cited by this paper
• C‐reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones

  2004cited by this paper
• Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus

  2004influential reference
• Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes

  2004cited by this paper
• Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

  2003cited by this paper
• Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

  2003cited by this paper
• Hyperglycemia as a cardiovascular risk factor.

  2003cited by this paper
• Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins 1990 to 2001

  2003cited by this paper
• Diabetic macrovascular disease: the glucose paradox?

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

  2002cited by this paper
• Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed.

  2002cited by this paper
• Systematic reviews in health care: Assessing the quality of controlled clinical trials.

  2001cited by this paper
• The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus.

  2001cited by this paper
• Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

  2000influential reference
• Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria

  1999cited by this paper
• Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe.

  1999cited by this paper
• Confidence intervals for the number needed to treat

  1999cited by this paper
• Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis.

  1999cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test. Graphical test is itself biased.

  1998cited by this paper
• Confidence intervals for the number needed to treat

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Bias in meta›analysis detected by a simple, graphical test

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.

  1997influential reference
• Meta-analysis: Potentials and promise

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Explaining heterogeneity in meta-analysis: a comparison of methods.

  1997cited by this paper
• Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria

  1995cited by this paper
• Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial.

  1995cited by this paper
• Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.

  1995cited by this paper
• Mortality and Treatment Side-Effects During Long-Term Intensified Conventional Insulin Treatment in the Stockholm Diabetes Intervention Study

  1994cited by this paper
• Metformin Improves Glucose, Lipid Metabolism, and Reduces Blood Pressure in Hypertensive, Obese Women

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Glycation Products and the Pathogenesis of Diabetic Complications

  1992cited by this paper
• UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

  1991cited by this paper
• Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies

  1991cited by this paper
• Role of Oxidative Stress in Development of Complications in Diabetes

  1991cited by this paper
• A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: causes and death rates

  1990cited by this paper
• Long-term correction of hyperglycemia and progression of retinopathy in insulin dependent diabetes. A five-year randomized prospective study.

  1988cited by this paper
• Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study.

  1983cited by this paper
• Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study.

  1983cited by this paper
• Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications.

  1978cited by this paper

• Guía de práctica clínica sobre Diabetes Mellitus Tipo 1

  2026cites this paper
• Correlation Between Glycated Hemoglobin (HbA1c) Levels and Lipid Profile in Patients With Type 2 Diabetes Mellitus at a Tertiary Hospital in Saudi Arabia

  2025cites this paper
• Targeting Myostatin as an Adjunct Treatment for the Preservation of Cardiometabolic and Skeletal Muscle Function in Type 1 Diabetes

  2025cites this paper
• Trends in baseline HbA1c and body-mass index in randomised trials of people with type 1 diabetes from 1993 to 2025: an IMI2 SOPHIA systematic review and meta-analysis

  2025cites this paper
• Inhibidores del cotransportador de sodio-glucosa tipo 2

  2025cites this paper
• Long-term tracking of glycosylated hemoglobin levels across the lifespan in type 1 diabetes: from infants to young adults

  2024cites this paper
• The Vital Role of Pharmacists in Diabetes Self-care

  2024cites this paper
• Sleep quality and glycemic control in adults with type 2 diabetes mellitus

  2024cites this paper
• Modeling the Clinical and Economic Burden of Therapeutic Inertia in People with Type 2 Diabetes in Saudi Arabia

  2024cites this paper
• Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry

  2024cites this paper
• Major adverse cardiovascular events’ reduction and their association with glucose‐lowering medications and glycemic control among patients with type 2 diabetes: A retrospective cohort study using electronic health records

  2024cites this paper
• The association between type 1 diabetes and exercise/physical activity and prolongation of the honeymoon phase in patients.

  2023cites this paper
• COVID-19 and metabolic syndrome

  2023cites this paper
• Glycometabolic Outcomes in Adult Type 1 Diabetic Patients Switching To Closed-Loop Systems.

  2023cites this paper
• Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy

  2023cites this paper
• Predictors of glycemic and weight responses to exenatide in patients with type 2 diabetes mellitus

  2023cites this paper
• CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece

  2023cites this paper
• Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Metabolism: Insights into Health and Disease

  2023cites this paper
• Correlation of glycated haemoglobin status with the foot ulcer

  2023cites this paper
• Fukushima study for Engaging people with type 2 Diabetes in Behaviour Associated Change (FEEDBACK): study protocol for a cluster randomised controlled trial

  2023cites this paper
• Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands

  2023cites this paper
• Use of herbal medicines for the management of type 2 diabetes: A systematic review of qualitative studies.

  2023cites this paper
• Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK

  2023cites this paper
• Diabetes and infectious disease mortality in Mexico City

  2023cites this paper
• A review on the effect of garlic on diabetes, BDNF, and VEGF as a potential treatment for diabetic retinopathy

  2023cites this paper
• Efficacy and safety of intensive versus conventional glucose targets in people with type 2 diabetes: a systematic review and meta-analysis

  2023cites this paper
• Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician

  2023cites this paper
• Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China

  2022cites this paper
• The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK

  2022cites this paper
• Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessment

  2022cites this paper
• Once‐weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long‐term cost‐effectiveness analysis based on SUSTAIN 11

  2022cites this paper
• Treatment Adherence and Incidence of Coronary Heart Disease in Type 2 Diabetes Mellitus Patients

  2022cites this paper
• Typ-1-Diabetes und kardiovaskuläre Risikofaktoren bei Kindern und Jugendlichen

  2022cites this paper
• The prevalence of Type 2 Diabetes among people living with HIV in Georgia

  2022cites this paper
• Features of self-management of type 2 diabetes mellitus: assessment results of qualitative and quantitative parameters

  2022cites this paper
• Evaluation of lipid profile and glycated haemoglobin in type 2 diabetic patients

  2022cites this paper
• Novel Targets and Interventions for Cognitive Complications of Diabetes

  2022cites this paper
• The effects of oral magnesium supplementation on glycaemic control in patients with type 2 diabetes: a systematic review and dose–response meta-analysis of controlled clinical trials

  2022cites this paper
• Glycemic control and the risk of tuberculosis in patients with diabetes: A cohort study in a Mediterranean city

  2022cites this paper
• The Cost-Effectiveness of Oral Semaglutide in Spain: A Long-Term Health Economic Analysis Based on the PIONEER Clinical Trials

  2022cites this paper
• Glycated albuminandHbA1cas markers of lower extremity disease inUS adults with and without diabetes.

  2022cites this paper
• Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China

  2022cites this paper
• Sleep and type 1 diabetes mellitus management among children, adolescents, and emerging young adults: A systematic review.

  2021cites this paper
• Diabetes Management in Patients with Heart Failure

  2021cites this paper
• Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe

  2021cites this paper
• The long-term cost-effectiveness of oral semaglutide in the Netherlands based on the PIONEER 2, 3 and 4 randomized controlled trials.

  2021cites this paper
• The Effect of a Single Bout of Continuous Aerobic Exercise on Glucose, Insulin and Glucagon Concentrations Compared to Resting Conditions in Healthy Adults: A Systematic Review, Meta-Analysis and Meta-Regression

  2021cites this paper
• The economic burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in Denmark

  2021cites this paper
• What makes poor diabetic control worse? A cross-sectional survey of biopsychosocial factors among patients with poorly controlled diabetes mellitus in Malaysia

  2021cites this paper
• The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data

  2021cites this paper
• Heart failure outcomes and glucagon-like peptide-1 receptor agonists: A systematic review of observational studies.

  2021cites this paper
• Hyperglycemic memory in diabetic cardiomyopathy

  2021cites this paper
• GLYCOSYLATED HEMOGLOBIN PROGNOSTICATES DYSLIPIDEMIA-A RETROSPECTIVE STUDY

  2021cites this paper
• Importance of Awareness and Treatment for Diabetes in Influenza Vaccination Coverage of Diabetic Patients under 65 Years: A Population-Based Study

  2020cites this paper
• Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2020cites this paper
• Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2020cites this paper
• Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia

  2020cites this paper
• Predicting 5- and 10-Year Mortality Risk in Older Adults With Diabetes

  2020cites this paper
• Associations of visit-to-visit fasting glucose with risk of mortality: A retrospective cohort study of 48,077 people with type 2 diabetes.

  2020cites this paper
• The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain

  2020cites this paper
• Status of Glycaemic Control in Patients Attending Endocrine OPD in a Tertiary Care Hospital in Bangladesh

  2020cites this paper
• Complex management in diabetic patients with cardiovascular disease

  2020cites this paper
• Temporal evolution of cardiac mitochondrial dysfunction in a type 1 Diabetes model. Mitochondrial complex I impairment, and H2O2 and NO productions as early subcellular events.

  2020cites this paper
• Cardiovascular diseases in youth patients with glucose metabolism impairment

  2020cites this paper
• Study of Glycated Haemoglobin and Lipid Profile in Patients with Diabetic Foot Ulcer

  2020cites this paper
• Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK

  2020cites this paper
• Effectiveness and safety of insulin glargine 300 unit/mL in Japanese type 2 diabetes mellitus patients: a 12-month post-marketing surveillance study (X-STAR study)

  2020cites this paper
• Relationship of type 2 diabetes mellitus and cardiovascular pathology: significance of glycemic control on the way to solving the problem

  2020cites this paper
• The 100 Top-Cited Systematic Reviews/Meta-Analyses on Diabetic Research

  2020cites this paper
• Impact of haemoglobin A1c trajectories on chronic kidney disease progression in type 2 diabetes

  2019cites this paper
• The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia

  2019cites this paper
• Cost-of-illness and its determinants for type 2 diabetes mellitus in Bangladesh:

  2019cites this paper
• Reply: Managing Diabetes and Preventing Heart Disease: Have We Found a Safe and Effective Agent?

  2019cites this paper
• Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting

  2019cites this paper
• Enfermedad arterial periférica y estrés oxidativo en pacientes del programa para la prevención de complicaciones de diabetes mellitus y dislipidemias

  2019cites this paper
• Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial

  2019cites this paper
• Diabetes Distress, Intentional Hyperglycemia at Work, and Glycemic Control Among Workers With Type 1 Diabetes

  2019cites this paper
• Determinants of hypertension among diabetic patients in Public Hospitals of the Central Zone, Tigray, Ethiopia 2018: unmatched case-control study

  2019cites this paper
• Describing medicine therapy management of type 2 diabetes mellitus at primary health care facilities in Cape Town

  2019cites this paper
• Full title: High glucose protects mesenchymal stem cells from metformin-induced apoptosis through the AMPK-mediated mTOR pathway

  2019cites this paper
• Association between glycated hemoglobin (HbA1c) and the lipid pro fi le in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study Targets and Therapy

  2019cites this paper
• Peripheral artery disease and oxidative stress in patients in a program for preventing complications of diabetes mellitus and dyslipidemia

  2019cites this paper
• Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA

  2019cites this paper
• A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA

  2019cites this paper
• Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study

  2019cites this paper
• Hemoglobinopati, Asetil Salisilik Asit Kullanimi Ve Üreminin İmmünoturbidimetrik Ve HPLC Hemoglobin A1c Ölçümleri Üzerine Etkileri

  2019cites this paper
• Glycaemic Control for People with Type 2 Diabetes Mellitus in Bangladesh - An urgent need for optimization of management plan

  2019cites this paper
• A Game Theoretic Approach to Peer Review of Grant Proposals

  2019cites this paper
• Sustained 52‐week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes

  2019cites this paper
• Facteurs associés au mauvais contrôle glycémique chez des diabétiques de type 2 au Nord-Est du Maroc : à propos de 80 cas

  2019cites this paper
• Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes

  2019cites this paper
• Managing Diabetes and Preventing Heart Disease: Have We Found a Safe and Effective Agent?

  2018cites this paper
• Toward the Development of a Glucose Dehydrogenase-Based Saliva Glucose Sensor Without the Need for Sample Preparation

  2018cites this paper
• Exploring the role of self-compassion in adolescent wellbeing and type 1 diabetes management

  2018cites this paper
• Efficacy and safety of adding single dose insulin glargine in patients with type 2 diabetes uncontrolled by oral hypoglycemic drugs

  2018cites this paper
• Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia

  2018cites this paper
• Ideglira is Associated With Improved Short-Term Clinical Outcomes and Cost Savings Compared with Insulin Glargine U100 Plus Insulin Aspart in the U.S.

  2018cites this paper
• Clinical inertia among patients with type 2 diabetes mellitus treated with DPP-4i and/or SGLT-2i.

  2018cites this paper
• Evaluation of the long‐term cost‐effectiveness of once‐weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK

  2018cites this paper
• The Development of a Glucose Dehydrogenase 3D-Printed Glucose Sensor: A Proof-of-Concept Study

  2018cites this paper